| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $72.6M | +105.8% |
| R&D Expense | $240.3M | +38.9% |
| SG&A Expense | $79.4M | +10.0% |
| Operating Income | -$247.1M | -17.7% |
| Pre-tax Income | -$218.8M | -25.9% |
| Income Tax | $152K | +103.2% |
| Net Income | -$219.0M | -29.5% |
| EPS (Basic) | -$3.16 | -9.0% |
| EPS (Diluted) | -$3.16 | -9.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $628.1M | -28.6% |
| Accounts Receivable | $0 | — |
| Current Assets | $682.9M | -26.5% |
| Total Assets | $717.6M | -25.0% |
| Current Liabilities | $57.0M | -15.2% |
| Total Liabilities | $107.6M | -34.3% |
| Stockholders' Equity | $610.0M | -23.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$249.7M | -51.6% |
| Capital Expenditures | $2.4M | +90.3% |
| Investing Cash Flow | -$2.4M | -90.3% |
| Financing Cash Flow | -$131K | -100.0% |
| Free Cash Flow | -$252.0M | -51.9% |